Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/PY3 stock hub

FRA/PY3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/PY3is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

42B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/PY3

In the news

Latest news · FRA/PY3

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E45.6

P25 n/aP50 n/aP75 n/a

Trailing P/E80.5

P25 n/aP50 n/aP75 n/a

ROE7.7

P25 n/aP50 n/aP75 n/a

ROIC8.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/PY3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

199

Groups with data

Currency

USD

Showing 199 of 199 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	DE
Employees	7,676
Employees Change	1,131%
Employees Change Percent	17.28
Enterprise value	EUR 43.7B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 42B
Price	EUR 179
Price currency	EUR
Rev Per Employee	581,521.59x
Sic	2834
Symbol	fra/PY3
Website	https://www.galderma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.24%
EV Earnings	83.74x
EV/EBIT	57.02x
EV/EBITDA	43.09x
EV/FCF	47.88x
EV/Sales	9.63x
FCF yield	2.17%
Forward P/E	45.56x
P/B ratio	6.05x
P/E ratio	80.46x
P/S ratio	9.41x
PE Ratio3 Y	108.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.89%
EBITDA Margin	21.64%
FCF margin	20.45%
Gross margin	68.86%
Gross Profit	EUR 3.1B
Gross Profit Growth	11.18%
Gross Profit Growth Q	23.63%
Gross Profit Growth3 Y	6.32%
Gross Profit Growth5 Y	8.4%
Net Income	EUR 522.1M
Net Income Growth	165.37%
Net Income Growth Q	127.72%
Pretax Margin	12.19%
Profit Margin	11.7%
Profit Per Employee	EUR 68,016
ROA	4.25
ROCE	7.81
ROE	7.69
ROIC	8.39
Roic5y	-2.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	70.92%
EPS Growth	166
EPS Growth Q	129.1
FCF Growth	197.78%
FCF Growth Q	67.86%
FCF Growth3 Y	59.74%
FCF Growth5 Y	49.03%
OCF Growth	142.83%
OCF Growth Q	58.5%
OCF Growth3 Y	41.42%
OCF Growth5 Y	43.36%
Revenue Growth	18.04x
Revenue Growth Q	24.78x
Revenue Growth3 Y	6.67x
Revenue Growth5 Y	8.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.4
Assets	EUR 11.4B
Cash	EUR 664.3M
Current Assets	EUR 2.1B
Current Liabilities	EUR 1.7B
Debt	EUR 2.3B
Debt EBITDA	EUR 2.35
Debt Equity	EUR 0.34
Debt FCF	EUR 2.57
Equity	EUR 6.9B
Interest Coverage	5.12
Liabilities	EUR 4.5B
Long Term Assets	EUR 9.3B
Long Term Liabilities	EUR 2.7B
Net Cash	EUR -1.7B
Net Cash By Market Cap	EUR -4
Net Debt EBITDA	EUR 1.74
Net Debt Equity	EUR 0.24
Net Debt FCF	EUR 1.84
Tangible Book Value	EUR -1.4B
Tangible Book Value Per Share	EUR -5.88

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.19
Inventory Turnover	3.52
Net Working Capital	EUR -283.6M
Quick ratio	0.9
Working Capital	EUR 325.3M
Working Capital Turnover	EUR 12.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.34%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	EUR 0.38
Dividend Years	2
Dividend Yield	0.21%
Ex Div Date	2026-04-24
Last Dividend	EUR 0.38
Payout Frequency	Annual
Payout Ratio	6.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	70.85%
200-day SMA	157.3
50-day SMA	166.5
50-day SMA vs 200-day SMA	50over200
All Time High	199
All Time High Change	-10.05%
All Time High Date	2025-12-10
All Time Low	100
All Time Low Change	79%
All Time Low Date	2025-05-28
ATR	5.13
Ch YTD	4.68
High	183
High52	199
High52 Date	2025-12-10
High52ch	-10.05%
Low	177
Low52	100
Low52 Date	2025-05-28
Low52ch	79%
Ma50ch	7.49%
Price vs 200-day SMA	13.79%
RSI	57.56
RSI Monthly	0
RSI Weekly	61.99
Sharpe ratio	1x
Sortino ratio	1.78
Total Return	0.54%
Tr YTD	4.91
Tr1m	8.07%
Tr1w	0.56%
Tr3m	14.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 753.8M
Operating Income Growth	18.47
Operating Income Growth Q	38.76
Operating Income Growth3 Y	12.29
Operating Income Growth5 Y	20.42
Operating margin	16.89

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	96,818,495%
Net Borrowing	-248,452,866
Shares Institutions	31.77%
Shares Qo Q	-0.6%
Shares Yo Y	-0.34%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 858.5M
Average Volume	26.25x
Bv Per Share	29.59
CAPEX	EUR -96.2M
Ch1m	7.83
Ch1w	0.56
Ch1y	70.48
Ch3m	14.01
Ch6m	18.54
Change	-2.19%
Change From Open	-2.19
Close	183
Days Gap	0
Depreciation Amortization	211,142,538
Earnings Date	2026-07-23
EBIT	EUR 753.8M
EBITDA	EUR 965.8M
EPS	EUR 2.2
F Score	7
FCF	EUR 913M
FCF EV Yield	2.09x
Financing CF	-620,037,600
Fiscal Year End	December
Founded	1,981
Goodwill	4,349,197,098
Graham Number	38.47396
Graham Upside	-78.51
Income Tax	EUR 22.1M
Investing CF	-131,161,800
Is Primary Listing	0
Last Report Date	2025-12-31
Ma150	161.4
Ma150ch	10.93%
Ma20	173
Ma20ch	3.47%
Net CF	275,099,100
Next Earnings Date	2026-07-23
Open	183
P FCF Ratio	46.01
P OCF Ratio	41.62
Payment Date	2026-04-28
Position In Range	33.33
Ppne	630,883,728
Price Date	2026-05-08
Price EBITDA	EUR 43.5
Relative Volume	3.81x
Revenue	4,463,759,700x
SBC By Revenue	1.22x
Share Based Comp	54,508,800
Tax By Revenue	0.5x
Tax Rate	4.07%
Tr6m	18.81%
Volume	0
Z Score	5.36

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/PY3 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.2%

$0.38 annual per share

Payout ratio

+6.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+0.5%

Next ex-dividend date: 2026-04-24

Performance

FRA/PY3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/PY3?

Insider, institutional, and short-interest positioning.

Institutional ownership

+31.8%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.3%

Negative means the company is buying back shares.

Technical

FRA/PY3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.6

Neutral momentum band

Price vs 200-day MA

+13.8%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/PY3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/PY3 stock rating?

fra/PY3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/PY3 analysis?

The full report lives at /stocks/fra/PY3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/PY3?

The latest report frames fra/PY3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/PY3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.